# Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults

> **NCT01811823** · PHASE4 · COMPLETED · sponsor: **University of Witwatersrand, South Africa** · enrollment: 301 (actual)

## Conditions studied

- Influenza
- HIV
- Tuberculosis

## Interventions

- **BIOLOGICAL:** Trivalent Inactivated Influenza Vaccine

## Key facts

- **NCT ID:** NCT01811823
- **Lead sponsor:** University of Witwatersrand, South Africa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-31
- **Primary completion:** 2014-11-20
- **Final completion:** 2014-11-20
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2018-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01811823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01811823, "Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01811823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*